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Basement membrane collagen in the kidney: Regional localization of
novel chains related to collagen IV. Variability in the collagen chain
composition of renal basement membranes was demonstrated by im-
munofluorescent microscopy using polyclonal and monoclonal antibod-
ies and correlating with imaging of the glomerular basement membrane
by phase microscopy. Antibodies toward the globular domains of alpha
1(IV) and alpha 2(IV) collagen chains, triple helical and 7S domains of
collagen IV bind within the glomerulus to mesangial matrix, along the
subendothelial region of the glomerular capillary wall, and to all tubular
and vascular basement membranes. The portion of glomerular base-
ment membrane corresponding to the phase dense image is not reactive
with these antibodies (pattern I). A different binding pattern is seen
with antibodies against two novel globular regions of basement mem-
brane collagen chains which bind to the phase dense aspect of glomer-
ular basement membrane and to Bowman's capsule (pattern 2). Human
tubular basement membrane is not reactive, except along portions of
the distal tubule, whereas bovine tubular basement membrane is
diffusely reactive; mesangial matrix and extraglomerular vascular base-
ment membranes are not reactive. Although a possible explanation for
the regional distribution of basement membrane collagen antigens in the
glomerulus may relate to antigen exposure, a more likely reason is that
collagen chains are regionally expressed. The staining patterns suggest
that the novel collagen chains have a selective tissue distribution
compared with alpha I (IV) and alpha 2(IV) chains and that the
glomerular cells of origin of these collagen IV chains may differ.
Collagen IV is a major structural component of basement
membranes (BM). Much of our present knowledge about the
macromolecular structure and interactions of collagen IV has
been gained from studies of a BM secreting tumor, the EHS
sarcoma [1]. Two chains with the molecular formula (alpha 1)2
alpha 2 are believed to comprise most collagen IV molecules
from the EHS tumor and BM. The two chains have a minor
triple helical domain at their amino termini, a major helical
domain in the central region, and a globular domain at their
carboxy-termini.
The carboxy-terminal globular (non-collagen 1 or NC 1) do-
main and the amino terminal helical domain are sites where
junctions exist between molecules in BM matrices [1]. The NC1
domains from two collagen IV molecules can interact to form
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one type of intermolecular junction, and another exists at the
amino terminal helical domains, the 7S region, where four
molecules interact. Bacterial collagenase digestion of BM re-
leases the globular domains as 160 kd hexamers—the hexamers
being comprised of NC1 from two collagen molecules. Each
collagen chain contributes a monomer to the hexameric struc-
ture. Some of the monomers are covalently bonded into dimers.
Studies of the EHS tumor, and of the biosynthesis of collagen
IV by PF-HR9 cells have indicated that the dimers arise by
intermolecular crosslinking between monomers [1, 21, but not
by disulfide bonding within the same triplet molecule.
Recent investigations of the collagenase-resistant globular
domains from bovine glomerular and lens capsule BM have
revealed the existence of two additional monomers (M2 and
M3) and corresponding dimers besides those that are derived
from alpha l(IV) and alpha 2(IV) chains. The parent chains
from which M2 and M3 are derived were termed alpha 3(IV)
and alpha 4(IV) chains, respectively [31.
The BM antigen recognized by antibodies from patients with
Goodpasture syndrome was identified as M2 in bovine glomer-
ular BM (GBM) [4]. Both M2 and M3 are found in human GBM
[5]; however, Kleppel et al have demonstrated by Western
blotting experiments that each of the four monomers that they
identified (M24, M26, M28 and M28) in collagenase di-
gests of human GBM reacts with Goodpasture antibodies [6].
The cationic human monomer, M28 is the most reactive
monomer in the latter study. Indeed, M28 + has been shown
to be immtmochemically identical to M2 (manuscript in prepa-
ration).
Goodpasture antibodies bind the central portion of the GBM
and distal tubular BM (TBM) as analyzed by immunofluores-
cent microscopy. Goodpasture antibodies do not bind mesan-
gial matrix, proximal tubular, or other renal BM; however,
when the tissue is pretreated by denaturation with acid-urea,
additional epitopes are exposed and antibody binding is diffuse
on TBM and Bowman's capsule, but not within the mesangium
or on vascular BM [7]. These observations suggest heterogene-
ity in distribution and/or presentation of antigens of the globular
domain(s) of BM collagen. Since Goodpasture antibodies may
react with all human NC 1 monomers [6], one cannot ascertain
which antigens are being bound by these antibodies under
native versus denatured conditions. A monoclonal antibody
toward the Goodpasture epitope, described by Pusey et al [8]
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Table 1. Domains of basement membrane type IV collagen: Collagen cham derivations and antibody reagentsa
Human Domains Bovine domains
Domain derivation: Parent collagen chainDomain Antibodies' Domain Antibodies"
M26
M24
M28 + +
M2W
Triple helix
7S collagen
Monoclonal
Polyclonal
—
Monoclonal
Monoclonal
Monoclonal
Mla
Ml b
M2
M3
Triple helix
iS collagen
Polyclonal, Monoclonal
—
Polyclonal, Monoclonal
Polyclonal
—
—
Globular domain of alpha l(IV)
Globular domain of alpha 2(IV)
Globular domain of undefined collagen chainc
Globular domain of undefined collagen chai&
Major triple helix of alpha 1(IV) and alpha 2(IV)
Triple helical crosslinking region of alpha l(tV) and
alpha 2(IV)
a The fragments listed are the monomeric forms of the collagenase-resistant regions of basement membrane collagen chains, as previously
defined 13, 6]. The identities between human and bovine fragments were established immunochemically. Parent chain origins are based on amino
acid sequence comparisons for alpha l(IV) and alpha 2(IV).
"The antibody reagents used in the present study are listed; two monoclonal antibodies to both human M26 and bovine MIa were used. See
Methods for antibody characterization.
"The parent chains for M28 ++ and M28" have not been characterized to date, and have tentatively been defined as alpha 3(IV) and alpha 4(IV),
as described previously [3]. The nomenclature used in this study has previously been defined for human GBM [6].
exhibits a pattern of binding that is similar to that of Good-
pasture antibodies under native conditions, likewise suggesting
restricted distribution or presentation of BM collagen antigens.
Since this antibody binds multiple monomeric and dimeric
subunits in collagenase digests of human GBM, it is not known
which antigen(s) are reacting in the immunofluorescent analy-
sis.
Kleppel et at developed a monoclonal antibody that binds
only M3 (M28) and related dimers by Western blotting [9].
They observed by immunofluorescence of native and denatured
tissue sections that this monoclonal antibody binds to GBM and
distal tubule BM, Thus, M3 antigen appears to either exhibit
specific renal BM localization or exposure of M3 to antibody is
restricted even upon denaturation.
The following studies were performed to further examine the
issue of BM collagen antigen distribution in the kidney. Poly-
clonal and monoclonal antibodies reactive with the noncollage-
nous monomers from human and bovine GBM were evaluated
by immunofluorescence on native and denatured tissue sec-
tions. Antibodies toward NC1 regions of alpha l(IV) and alpha
2(IV) chains give a distribution pattern identical to that seen
with antibodies toward the major triple helical region and 7S
domain of collagen IV; however, antibodies toward M2 and M3
present a different distribution. The results collectively indicate
that the globular domains of BM collagen are selectively
distributed among renal BM.
Methods
Antigens
The antigens in this study are collagenase-resistant globular
fragments (24 to 30 Kda) of basement membrane collagen
chains. They represent the NC1 domains of alpha l(IV) and
alpha 2(IV) chains, and globular regions (M2 and M3) of other
basement membrane collagen chain(s) that have recently been
described [3, 41. The collagen parent chain(s) from which M2
and M3 are derived have not been characterized, but were
tentatively named alpha 3(IV) and alpha 4(IV). The amino
terminal of each fragment has Gly-X-Y triplets and hydroxy-
proline, indicative of a collagenous derivation, followed by
non-collagenous amino acid sequences [31. Monomeric forms of
the fragments were previously defined as Ml a [derived from
alpha l(IV)], Mlb [from alpha 2(IV)], M2 and M3 [from alpha
3(IV) and alpha 4(IV)] in bovine basement membranes [3], and
as M26, M24, M28 and M28, respectively, in human GBM
[6]. Human M26 corresponds to bovine Mla, M24 to bovine
Mlb, M28 to bovine M2 and M28" to bovine M3 as
determined by reactivity with the antibodies described below.
Antigen nomenclature used in this work is summarized in Table
1 and represents that defined for human GBM [6].
Antibodies
Polyclonal antisera against bovine Mla, M2 and M3 were
raised in rabbits by standard procedures, as previously de-
scribed [41. Their specificity for the respective monomers was
demonstrated by Western blotting and ELISA with isolated
bovine monomers [3]. The presence of Mia, M2 and M3 in
human GBM has been established by Wieslander, Kataja and
Hudson on the basis of reactivity of isolated human monomers
with these antibodies [5]. Bovine M2 reacts with rabbit anti-M2
and with Goodpasture antibodies. Human M28 reacts
strongly with the latter antibodies, however, other human
monomers also react with Goodpasture antibodies, but to a
lesser degree [6]. Antibodies toward human M24 were raised in
sheep immunized initially with 50 tg of antigen in complete
Freund's adjuvant, followed by a second immunization in
incomplete adjuvant. Anti-M24 was demonstrated to be specific
by ELISA having a dilution titer of >1:20,000 against M24, and
<1:500 with M26.
Monoclonal antibodies toward bovine Mla and M2 were
developed by BioCarb Chemicals, Lund, Sweden (Wieslander
J, Butkowski RJ, manuscript submitted). A monoclonal anti-
body directed toward the major triple helical domain of collagen
IV alpha 1 and 2 chains was obtained from ICN Immunochem-
icals (Lisle, Illinois, USA). This antibody binds to a site 55 nm
from the 75 domain. Monoclonal antibody toward human M28
was previously described [9] and two monoclonal antibodies
toward human M26 were developed using standard procedures,
as previously described [10]. Clones were examined by ELISA
using NC 1 as the coating antigen. Reactive clones were further
screened by immunofluorescence, and positive clones were
finally selected by Western blotting using NC1 as the target
antigen. Clones that were positive by these criteria were chosen
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for limiting dilution. Anti-human M281 was shown to react with
bovine M3 by ELISA; and anti-bovine M2 reacted with human
M28. Two monoclonal antibodies against bovine alpha
l(IV) NC1 reacted with human M26, thus establishing the
correspondence between the human and bovine monomers.
The antibodies and antibody nomenclature used in this study
are summarized in Table 1.
Iminunofluorescent microscopy
Indirect immunofluorescent analysis was performed as pre-
viously described, using fluorescein-labelled secondary anti-
bodies [10]. Cortical slices of human and bovine kidneys were
snap frozen in isopentane precooled in liquid nitrogen. Two
micron sections of frozen tissue were obtained and processed
for immunohistochemical analysis. Antibodies were tested on
tissue that was processed in the conventional way, and also
following tissue denaturation by incubation with acid-urea [71.
Tissue distribution patterns were analyzed under 160 x magni-
fication. Spatial distribution within the BM was analyzed by
high-resolution phase contrast microscopy and epifluorescence.
Antibody localization was determined by visually alternating
phase-contrast and epifluorescence, or by superimposing the
images photographically. By this method, it was possible to
distinguish two staining patterns within glomerular capillary
wall, as previously described [111. Pattern I was characterized
by subendothelial staining internal to the phase-dense image of
the GBM in contiguity with the mesangium. Pattern 2 was
characterized by a fluorescent image that had the same config-
uration as the phase-dense image of the GBM. When this
pattern was seen, fluorescence was observed to coincide with
both peripheral aspects of the GBM as well as the more
proximal GBM reflections adjacent to the mesangium; there
was no staining of the endothelial-mesangial region or the
mesangium. Patterns 1 and 2 were compared on the same tissue
section in double-antibody experiments. In this study the first
antibody, sheep anti-M24, was applied to the tissue and reacted
with fluorescein-conjugated anti-sheep IgG followed by mono-
clonal anti-M28 and rhodamine-conjugated anti-mouse IgG
[11].
Results
Characterization of antibodies
Polyclonal antibodies toward bovine NC 1 fragments were
defined by ELISA and Western blotting [4]. Each antibody is
specific for the appropriate fragment, shows negligible cross
reactivity with other fragments, and reacts with a correspond-
ing human GBM subunit. Sheep anti-human M24 [alpha 2(IV)
NC!] was characterized by ELISA with a titer of >1:20,000
dilution toward M24 and <1:500 toward M26 [alpha l(IV)
NC. Monoclonal antibodies specific for bovine Mia and M2
react by ELISA and Western blotting with human M26 and
M28 respectively. The monoclonal antibody toward human
M28 (Kieppel et al, manuscript submitted) reacts with bovine
M3 by ELISA. Since monoclonal antibodies reactive with both
bovine and human fragments were obtained for three of the four
globular domain fragments, the relationship between the human
and bovine fragments could be established. These relationships
were confirmed with the polyclonal antibodies. The globular
domain fragments and antibodies are summarized in Table 1.
Binding of polyclonal antibodies to bovine and human
kidneys
By immunofluorescence, antibodies toward M26 bound to all
basement membranes (pattern 1) of the bovine kidney (Fig. 1A).
The mesangium, Bowman's capsule, and TBM were most
reactive on the basis of fluorescence intensity, and other renal
basement membranes were somewhat less reactive (Table 2).
Sheep anti-M24 reacted weakly with Bowman's capsule and
TBM, however, following denaturation of the tissue with acid-
urea, anti-M24 stained brilliantly, giving a pattern identical to
that obtained with anti-M26 (not shown). A different staining
(pattern 2) was observed for anti-M28 (Fig. 1B). This
antibody showed intense staining of the glomerular capillary
basement membrane and the TBM. Mesangial matrix and
extraglomerular vascular basement membranes did not bind
this antibody. When reacted with tissue that was not denatured,
anti-M28 reacted weakly with bovine GBM and TBM, display-
ing a double granular pattern (not shown). Following denatur-
ation of tissues with acid-urea, anti-M28 stained brilliantly in
a pattern identical to that of anti-M28 Tissue denaturation
did not affect the staining pattern of anti-M26 ind anti-M28
although the fluorescence was mildly attenuated.
Analysis of human kidney sections (not shown) revealed a
staining pattern identical to that seen on bovine kidney with
polyclonal anti-M26 and anti-M24. Anti-M28 showed the
same pattern on human and bovine kidney, with the exception
that only focal staining of human TBM was detected. Denatur-
ation of the tissues prior to application of anti-M26 and anti-
M28 + resulted in a slight attenuation of fluorescence, but the
distribution did not change. Anti-M28 reacted similarly on
human and bovine kidneys in that tissue denaturation was
required to detect significant fluorescence. As with anti-
M28, most human TBM did not stain with anti-M28
antibody except for segments of distal tubule BM.
Glomerular staining patterns viewed at high magnification
revealed another difference between binding of anti-M26 and
anti-M24 compared with binding of anti-M28 ++ + and anti-
M28t The results are summarized in Table 2. Both anti-M26
and anti-M24 bound in a thin linear distribution along the inner
aspect of the capillary wall, blending with mesangial matrix at
the endotheliallmesangial interface and diffusely throughout the
mesangium (pattern 1). When the phase-dense image was
superimposed upon the fluorescence image, it was observed
that the fluorescence was on the capillary side of the phase-
dense image. These antibodies thus bound along the subendo-
thelial aspect of the glomerular capillary wall, whereas the
phase-dense aspect of the GBM was non-reactive. Anti-
M28 + and anti-M28 bound differently, suggesting a regional
distribution for these antigens. These two antibodies localized
in a pattern that was directly superimposed upon the phase-
dense image of GBM, indicating that these reagents bind more
centrally in the GBM (pattern 2). Binding of these antibodies
was continuous along the GBM and the epithelial/mesangial
interface where there was accentuated reactivity. The endothe-
lial/mesangial interface and the mesangium did not react with
anti-M28 or anti-M28. These features of pattern 2 result in
continuous ribbon-like staining for anti-M28 and anti-
M28, contrasting with the closed-loop or bow-like staining
with anti-M26 and anti-M24 (pattern 1).
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Fig. 1. Renal distribution of globular domain antigens from basement membrane collagen. Antigen distribution was analyzed by immunofluo-
rescence on 2 frozen sections. Two staining patterns are observed: pattern I is characterized by the staining of all renal basement membranes
and mesangial matrix, This pattern is illustrated in panels A, C, and E using polyclonal and monoclonal antibodies toward M26. Panel A represents
antibody binding to bovine kidney with a polyclonal anti-M26. Panel C illustrates that the same antibody binding pattern is seen on bovine kidney
with monoclonal antibodies toward M26. Panel E illustrates binding pattern I on human kidney with monoclOnal anti-M26.
Antibody binding pattern 2 is shown in panels B, D, and F. This pattern is characterized by restricted basement membrane staining. The GBM
is intensely stained, whereas mesangial matrix staining is absent. Extraglomerular basement membrane staining is limited to tubular basement
membranes. Panel B represents bovine kidney staining using polyclonal anti-M28 following acid/urea denaturation of the tissue. Panel D
illustrates monoclonal anti-M28 binding to bovine kidney following acid/urea denaturation, Panel F represents monoclonal anti-M28 binding
to human kidney. Note that staining pattern 2 is more restricted in human kidneys than in bovine kidneys. In the human kidney focal staining of
distal tubules is observed (panel F) whereas in bovine kidney most proximal tubules are stained (panels B and D). The controls (not shown)
revealed no tissue staining in the absence of primary antibodies. Antibody nomenclature and specificity is described in Table I. (Magnification: X 224.)
wlr
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Table 2. Localization of antibodies toward collagen domains on renal
basement membrane?
Locus
Antibody specificity
M28 M28 M24 M26 Helix 7S
GBMb
Phase dense 3+ 3+ — — — —
Subendothelium — — 2+ 2+ 2+ 2+
Mesangium — — 2+ 2+ 2+ 2+
Bowman's capsule 1+ 1+ 3+ 3+ 3+ 3+
TBM 2+ 2+ 3+ 3+ 3+ 3+
Vasdulard — — 2+ 2+ 2+ 2+
a Reactivity determined by indirect immunofluorescence with poly-
clonal and monoclonal antibodies on human and bovine kidneys.
Fluorescence intensity is indicated as negative (—), 1+, 2+ or 3+.' Phase dense staining is indicated for antibodies that bind in a
pattern superimposed on the phase dense image of GBM and mesangial
GBM. Subendothelial staining denotes binding to the subendothelial
region of the peripheral capillary, internal to the phase dense image of
the GBM.
Species differences are seen in antibody binding to TBM where in
the bovine kidney, M28 and M28 antibodies react diffusely with
TBM whereas in the human kidney only distal TBM reactivity is
evident.
d Antibody reactivity with peritubular capillary basement mem-
branes, arterial media and intima.
Staining with monoclonal antibodies on bovine and human
kidneys
Monoclonal antit,odies specific for M26, M28 ++ and M28
were applied to bovine and human kidney sections under native
conditions and following tissue denaturation. Pattern 1 staining
was observed for monoclonal anti-M26 reagents (Fig. 1C). The
mesangium, Bowman's capsule and TBM were intensely
stained, whereas the subendothelial aspect of the glomerular
capillary wall (Figs. lE, 2A) and the blood vessel basement
membranes stained somewhat less intensely. Pattern 1 features
reactivity of antibodies (Fig. 3A) with mesangium and endothe-
lial/mesangial interface, and the subendothelial space, which is
internal to the phase dense image of the GBM (Fig. 3C). This
pattern was observed with two monoclonal antibodies against
bovine M26 and with two other antibodies toward human M26.
Similar patterns were seen with human and bovine kidneys,
which did not change with tissue denaturation. Anti-bovine-
M26 monoclonal reagents stained the kidneys of both species
revealing pattern 1. Two monoclonal anti-human M26 antibod-
ies reacted on human kidney, but did not stain bovine kidney.
Pattern 2 was observed with monoclonal antibodies toward
M28 and M28 on both bovine (Fig. 1D) and human (Fig.
lF, 2B) kidney. These antibodies reacted with GBM but did not
stain the mesangial matrix, whereas Bowman's capsule and
distal tubular BM were stained. Basement membranes associ-
ated with vessels, including glomerular afferent arterioles of
bovine kidney did not stain. Both antibodies diffusely stained
bovine TBM whereas in human kidney only distal tubular BM
was reactive. The GBM staining with these antibodies was
ribbon-like and continuous due to binding along the GBM
epithelial/mesangial interface and (Figs. 2B, 3B) absence of
binding along the endothelial/mesangial interface. Fluorescent
and phase-dense images (Fig. 3C) were superimposable, indi-
cating that the antibodies bound to the GBM. These antibodies
fixed to basement membrane structures under both native
Fig. 2. Monoclonal antibodies toward basement membrane collagen
globulardomain subunits binding to glomerular loci. Panel A illustrates
human kidney reacted with monoclonal anti-M26. Mesangial matrix and
light capillary loop staining is observed (pattern 1). Panel B illustrates
acid/urea denatured human kidney reacted with monoclonal anti-M281.
The intense capillary loop staining and absence of mesangial loop
staining illustrated here is characteristic of pattern 2. Table 2 summa-
rizes the distribution of the collective renal basement membrane
collagen antigens. (Magnification x 1200.)
conditions and following denaturation. Upon denaturation,
staining with anti-M28 + was enhanced, but with anti-M28 + it
was somewhat attenuated.
Monoclonal antibodies toward the triple helical and 7S
domains of collagen IV
The observation that various antibodies toward M24 and M26
stain only the endothelial aspect of the glomerular capillary wall
suggests the possibility that collagen IV NC1 domain is re-
stricted in its distribution. To test whether the major triple
helical domain of collagen IV alpha 1 and alpha 2 chains is also
restricted to this locus, tissue sections were reacted with a
monoclonal antibody that binds a known site within the major
triple helical domain. Staining pattern 1 was observed with this
antibody on human kidney. The pattern was identical to that
observed with anti-M24 and anti-M26 as described above.
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Fig. 3. Illustrationof djfferential antibody binding to glomerular loci by dual antibody staining of the same human kidney section. The tissue was
reacted first with polyclonal sheep anti-M24, then stained with fiuorescein-conjugated anti-sheep Igu followed by mouse monoclonal anti-M28t,
and rhodamine-conjugated anti-mouse IgG. Pattern I staining is revealed by fluorescence (A) of the mesangium and subendothelial aspect of 0DM.
This contrasts with Pattern 2, in which rhodamine (B) staining is coincident with the phase dense image (large arrow) of the 0DM (C) (Magnification
x 1200),
Previous studies with a monoclonal antibody toward the 7S
domain of collagen IV have shown that this domain is similarly
expressed [12]. The observation with anti-7S was confirmed in
this study (not shown). As with the other antibodies directed
toward alpha l(IV) and alpha 2(IV) chains, staining pattern 1
was observed with anti-7S antibodies. Thus, all of the major
domains of alpha 1(IV) and alpha 2(IV) are detected in the
subendothelial and mesangial region of the glomerulus, but not
in the phase-dense aspect of the GBM.
Discussion
This study demonstrates two types of immunofluorescent
staining patterns on kidney sections reacted with antibodies
toward subunits of the globular domains of basement membrane
collagen. One staining pattern (pattern 1) is characterized by
antibody binding to the subendothelial aspect of the glomerular
capillary wall, the mesangial matrix, and vascular and tubular
basement membranes of the kidney. This pattern is seen with
several antibodies toward the helical and globular domain
subunits of alpha 1 (IV) and alpha 2(IV) chains. Another pattern
(pattern 2) is characterized by staining of the GBM as well as
Bowman's capsule and distal tubule BM. In this pattern,
staining of most TBM is intense in bovine kidney, whereas in
the human kidney only focal staining of distal tubule BM is
detected. Another feature of pattern 2 is the absence of staining
of both mesangium and basement membranes of extraglomeru-
lar blood vessels. This pattern was observed with all antibodies
toward M28 ++ and M28, the globular regions of the pro-
posed alpha 3 and alpha 4 chains of collagen IV [3].
The finding of two staining patterns is indicative either of
heterogeneous distribution of basement membrane collagen
chains or differential exposure and accessability of epitopes.
Regardless of which of these possibilities is ultimately estab-
lished, heterogeneity in BM collagen structural organization is
implied. While caution has been advised in drawing conclusions
concerning the presence or absence of antigens in individual
layers of GBM [101, one must consider the evidence in support
of local variation in BM collagen expression. Staining patterns
were consistently observed, and could be predicted based on
the biochemical characterization of individual globular domain
subunits and the specificity of numerous antibodies. When the
tissue was denatured to expose hidden antigens, the staining
patterns remained unchanged, except for polyclonal anti-M24
and anti-M28 antibodies, which did not bind significantly to
native basement membrane. Studies with the monoclonal anti-
body that binds the triple helical domain of collagen IV alpha 1
and alpha 2 chains at a site 55 nm from the 7S domain, and
another antibody toward the 7S domain further support the
concept of heterogeneous distribution of collagen chains in the
glomerular capillary wail. These antibodies displayed staining
pattern 1, similar to that obtained with the antibodies toward
the globular domains of these collagen chains. Previous studies
by Scheinman and Tsai demonstrated pattern 1 staining using a
monoclonal antibody toward the 7S domain of collagen IV [12],
and further suggested that all domains of collagen molecules
composed of alpha l(IV) and 2(IV) might occupy loci charac-
terized by pattern 1. These observations collectively suggest
that while collagen IV alpha 1 and 2 chains are present within
the subendothelial aspect of the glomerular capillary wall, the
phase-dense aspect of GBM either does not contain these
chains or their concentrations are too low to be detected by the
methods employed in this study.
These studies, using antibodies with more highly defined
specificities, extend the observations of Scheinman et al who
observed two GBM staining patterns with antibodies toward
collagen IV from the EHS tumor, placenta and from bovine lens
capsule [12, 131. In their work, antibodies to EHS tumor
procollagen IV and the 7S domain of placenta and GBM
collagen each bound to give a staining pattern like pattern 1,
whereas full thickness GBM staining was observed with anti-
bodies toward /3 chains of bovine lens capsule, basement
membrane collagen produced by limited pepsin digestion. De-
naturation of the tissue with S Mguanidine prior to staining did
not alter these basic patterns. It seems likely that their antibod-
ies to procollagen IV were directed toward regions of alpha
l(IV) and/or alpha 2(IV), and those toward lens capsule BM
may have been directed primarily toward collagen chains whose
distribution is similar to M28 and/or M28t Furthermore,
patterns 1 and 2 were observed by Houser et al on isolated
basement membranes with these antibodies [14]. Thus, anti-
body distribution patterns seem to be unrelated to the state of
tissue denaturation or to tissue handling.
By exposing renal tissue to guanidine, Huang distinguished
two classes of basement membrane matrix within the glomeru-
&J: >SF
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lus by electron microscopy [15]. One class was relatively
electron-lucent, and was associated with endothelial and
mesangial cells. Glomerular distribution of the latter is consis-
tent with pattern 1 described in the present work. The other
class is more electron-opaque, and is associated with epithelial
cells, consistent with pattern 2 described here. A theory that
could explain the differential glomerular staining patterns in the
present study, is that the antigens identified in staining pattern
1 are present in the lamina rara interna of the GBM and are
therefore associated with, and probably synthesized by endo-
thelial and mesangial cells. Antigens identified in staining pat-
tern 2 may be associated with the lamina densa and are likely to
be a product of the visceral epithelial cells.
The ultrastructural localization of collagen IV in GBM has
been reviewed [16]. Each of the ultrastructural investigations
utilized polyclonal antibodies toward collagen IV from the EHS
sarcoma. Collagen IV antibodies were found to localize to the
lamina densa in five reports, and in two studies the antibodies
also identified the lamina rarae. Courtoy, Timple and Farquehar
observed prominent staining in both the mesangium and GBM
by immunofluorescence [17]. Their ultrastructural studies re-
vealed predominant staining for collagen IV in the lamina
densa, with extensive staining of mesangial matrix. In light of
our present observations, these ultrastructural findings are
consistent with a combination of the two patterns that we see,
suggesting that the antibodies toward EHS collagen IV may be
directed toward the mixture of the various collagen chains. This
interpretation seems possible, except that M28 and M28
have not been detected in the EHS tumor matrix [61.
Ultrastructural evidence for pattern I antibody binding has
also been reported using antibodies toward EHS collagen IV.
One study employing immunogold antibody labeling, observed
collagen IV antibodies to localize on the inner half of the GBM,
being concentrated along the endothelial cell membrane [16]. In
another investigation, anti-EHS collagen IV localized to the
central lamina densa in normal rats, whereas in thickened GBM
of diabetic rats it localized to the subendothelial side [18].
Collectively, the ultrastructural studies suggest that there is
heterogeneity of collagen IV chain expression in the glomeru-
lus. The application of specific antibody probes for collagen
chain localization at the ultrastructural level will be required to
answer the questions raised by our immunofluorescent findings.
Our previous studies of immunofluorescent localization of
Goodpasture antibodies [11, 14] indicated a distribution pattern
consistent with pattern 2 which we observed here by immuno-
fluorescence using anti-M28 and anti-M28 reagents, By
electron microscopy, Goodpasture antibodies were localized in
the lamina rara interna and the lamina densa [19]. The zone of
lamina densa staining continued along the mesangial/endothelial
interface, becoming thicker in this region. The endothelial/
mesangial region and mesangial matrix were unstained. It is not
possible to directly compare ultrastructure immunohistology
with immunofluorescence on tissue sections; however, our
observations here of pattern 2 distribution of M28 and
M28 components are comparable to the combined lamina
densa/lamina rara intense staining previously observed by elec-
tron microscopy.
Site-specific expression of matrix components in the kidney
has been defined for other basement membrane components
using high-resolution immunofluorescence. Fibronectin and
collagen V are distributed similarly to M24 and M26 in that
these components are present within the mesangium and are
along with the internal aspect of the GBM [13, 20, 21]. Laminin
localizes to sites on either side of the central portion of the
GBM, and in the mesangial matrix [21]. Heterogeneity of
proteoglycan distribution within the glomerulus has been re-
ported [22]. Heparan sulfate proteoglycan was demonstrated by
immunohistochemistry, mainly in the GBM and to a lesser
extent, in the mesangium. In contrast, chondroitin and derma-
tan sulfate proteoglycans were found by antibody staining in the
mesangium and not in the GBM.
With Goodpasture antibodies, immunofluorescent staining
pattern 2 was seen on native tissue sections but upon denatur-
ation more extensive TBM reactivity was observed as in pattern
1, however, neither vascular BM nor mesangial reactivity was
evident [7]. These antibodies have been shown to be highly
reactive with M28 and less reactive with the other mono-
mers. Thus it appears that anti-M28 activity is seen on
tissue stained without denaturation, whereas upon denaturation
reactivity may be seen with other subunits besides M28.
These studies provide evidence for regional variation of the
collagen IV chain composition of mature basement membranes.
Their variable expression is suggestive of unique specialization
of the glomerular capillary wall and glomerular basement mem-
brane likely related to function. Furthermore, these findings
open new avenues of investigation into collagen IV triple helical
chain structure and intermolecular assembly. These studies
additionally provide insight into the primary genetic defect in
Alport syndrome [9] and relevance to studies of the target
antigen(s) of Goodpasture anti-GBM autoantibodies [3, 6].
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